Company Filing History:
1 out of 229 
1 out of 70 
Years Active: 2025
Title: Sachiko Hirokawa: Innovator in Antisense Oligonucleotide Technology
Introduction
Sachiko Hirokawa is a notable inventor based in Niigata, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antisense oligonucleotides. His work has implications for genetic research and therapeutic applications.
Latest Patents
Hirokawa holds a patent for an antisense oligonucleotide targeting ATN1 mRNA or pre-mRNA. This invention provides an antisense oligonucleotide that is formed of 15-22 nucleotides and is complementary to a nucleic acid including at least 15 consecutive bases in a specific target region of a base sequence of SEQ ID NO: 471, which encodes atrophin 1 (ATN1). The patent also covers pharmaceutically acceptable salts or hydrates of this oligonucleotide.
Career Highlights
Throughout his career, Hirokawa has worked with prominent organizations, including Nippon Shinyaku Company, Ltd. and Niigata University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Hirokawa has collaborated with esteemed colleagues such as Takao Kawano and Toshiaki Ode. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Sachiko Hirokawa's contributions to the field of biotechnology, particularly through his patent on antisense oligonucleotides, highlight his role as an influential inventor. His work continues to impact genetic research and therapeutic advancements.